A phase 2 clinical study of AVR-RD-01 in Patients With Fabry Disease

Trial Profile

A phase 2 clinical study of AVR-RD-01 in Patients With Fabry Disease

Planning
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs AVR 02 (Primary)
  • Indications Fabry's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Feb 2018 New trial record
    • 01 Feb 2018 According to a AVROBIO media release, company plans to initiate the study in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top